Clinical trial
Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma
NCT02282917 is registered in ClinicalTrials.gov with Massachusetts Eye and Ear Infirmary as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma
- Lead sponsor
- Massachusetts Eye and Ear Infirmary
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- December 31, 2015
- Completion date
- January 4, 2021
- Enrollment
- 7 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
acoustic neuroma, meningioma, neurofibromatosis type 2, vestibular schwannoma